Vanguard Group Inc Co Diagnostics, Inc. Transaction History

Vanguard Group Inc

$6.44 Trillion
Q3 2025

A detailed history of Vanguard Group Inc transactions in Co Diagnostics, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 1,705,952 shares of CODX stock, worth $580,023. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,705,952

Previous 1,733,245 1.57%

Holding current value

$580,023

Previous $485,000 19.59%

% of portfolio

0.0%

Previous 0.0%

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 07, 2025	SELL	$0.24 - $0.44 $6,550 - $12,008	-27,293 Reduced 1.57%	1,705,952 $580,000
Q2 2025 Aug 11, 2025	SELL	$0.23 - $0.38 $10,335 - $17,076	-44,937 Reduced 2.53%	1,733,245 $485,000
Q4 2024 Feb 11, 2025	SELL	$0.7 - $1.36 $2,170 - $4,217	-3,101 Reduced 0.17%	1,778,182 $1.33 Million
Q4 2022 Feb 10, 2023	BUY	$2.32 - $3.68 $410,470 - $651,091	176,927 Added 11.03%	1,781,283 $4.49 Million
Q3 2022 Nov 14, 2022	SELL	$2.87 - $7.01 $1.2 Million - $2.94 Million	-418,876 Reduced 20.7%	1,604,356 $5.15 Million
Q2 2022 Aug 12, 2022	BUY	$3.76 - $6.29 $568,955 - $951,790	151,318 Added 8.08%	2,023,232 $11.4 Million
Q1 2022 May 13, 2022	BUY	$5.03 - $9.61 $386,590 - $738,595	76,857 Added 4.28%	1,871,914 $11.6 Million
Q4 2021 Feb 14, 2022	SELL	$8.12 - $10.37 $22,191 - $28,341	-2,733 Reduced 0.15%	1,795,057 $16 Million
Q3 2021 Nov 12, 2021	SELL	$7.48 - $11.38 $380,335 - $578,638	-50,847 Reduced 2.75%	1,797,790 $17.5 Million
Q2 2021 Aug 13, 2021	BUY	$7.16 - $9.56 $13.2 Million - $17.7 Million	1,848,637 New	1,848,637 $15.3 Million

Others Institutions Holding CODX

# of Institutions

Shares Held

5.57M

Call Options Held

58K

Put Options Held

31.8K

View Full List

About Co-Diagnostics, Inc.

Ticker CODX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 33,781,000
Market Cap $11.5M
Description
Co-Diagnostics, Inc., a molecular diagnostics company, develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. It offers polymerase chain reaction (PCR) diagnostic tests for COVID-19, tuberculosis, hepatitis B and ...

More about CODX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Account

Vanguard Group Inc Co Diagnostics, Inc. Transaction History